These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15171356)

  • 21. [Role of vascular reactivity and neuronal factors in the development of hypertension].
    Nara Y; Yamori Y
    Nihon Rinsho; 1989 Sep; 47(9):1934-40. PubMed ID: 2593266
    [No Abstract]   [Full Text] [Related]  

  • 22. Functional state of the sympatho-adrenal system in essential hypertension.
    Lohmann FW; Dissmann T; Gotzen R; Molzahn M
    Ger Med; 1973; 3(3-4):95-7. PubMed ID: 4803045
    [No Abstract]   [Full Text] [Related]  

  • 23. [Role of the adrenergic system in the pathogenesis of essential arterial hypertension. Dynamic evaluation of plasma catecholamines].
    Cerasola G; Morici ML; Andronico G
    Recenti Prog Med; 1982 Mar; 72(3):284-303. PubMed ID: 7048461
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertension and coronary heart disease.
    Baguet JP; Mallion JM
    Blood Press; 2003; 12(4):255-6. PubMed ID: 14596363
    [No Abstract]   [Full Text] [Related]  

  • 25. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activity of sympatho-adrenal system in essential hypertension patients].
    Lohmann FW; Dissmann T; Gotzen R; Molzahn M; Schröder G
    Verh Dtsch Ges Inn Med; 1973; 79():809-12. PubMed ID: 4790003
    [No Abstract]   [Full Text] [Related]  

  • 27. [The adrenergic system in essential arterial hypertension].
    Fogari R; Marchesi E; Bongo A; Mocchi F
    Recenti Prog Med; 1979 Jul; 67(1):1-19. PubMed ID: 396614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Involvement of TNF-alpha in the pathogenesis of hypertension and hypertensive target-organ damage].
    Ura N; Sasaki H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():191-5. PubMed ID: 15171367
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension].
    Planz G; Corr H; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Verh Dtsch Ges Inn Med; 1975; 81():1066-8. PubMed ID: 1229400
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of the sympathetic-adrenal system in the pathogenesis of essential arterial hypertension].
    Manasia M; Spânu C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(6):481-8. PubMed ID: 6152066
    [No Abstract]   [Full Text] [Related]  

  • 31. The sympathetic nervous system in hypertension: differing effects of drug treatment.
    Sleight P
    Eur Heart J; 1998 Jun; 19 Suppl F():F39-44. PubMed ID: 9651734
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adrenosympathetic activity during sodium depletion in patients with essential hypertension].
    Agabiti-Rosei E; Alicandri C; Bentivoglio M; Corea L; Miele N; Muiesan G
    Boll Soc Ital Cardiol; 1977; 22(8):1413-20. PubMed ID: 618275
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of the sympathetic system in the maintenance of human hypertension.
    de Champlain J; Cousineau D; Lapointe L
    Clin Invest Med; 1978; 1(3-4):123-8. PubMed ID: 42501
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the sympathetic system in experimental and human hypertension.
    De Champlain J; Cousineau D; Van Amerigen MR; Marc-Aurèle J; Yamaguchi N
    Postgrad Med J; 1977; 53 Suppl 3():15-30. PubMed ID: 22071
    [No Abstract]   [Full Text] [Related]  

  • 36. [Borderline essential hypertension and the adrenergic nervous system. Identification assay].
    Cuche JL; Guédon J
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():107-15. PubMed ID: 6794524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamines and essential hypertension.
    Christensen NJ
    Scand J Clin Lab Invest; 1982 May; 42(3):211-5. PubMed ID: 6753096
    [No Abstract]   [Full Text] [Related]  

  • 38. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question.
    Julius S; Jamerson K
    J Hypertens; 1994 May; 12(5):495-502. PubMed ID: 7930548
    [No Abstract]   [Full Text] [Related]  

  • 39. Volume-independent mechanisms of hypertension in hemodialysis patients: clinical implications.
    Blankestijn PJ; Ligtenberg G
    Semin Dial; 2004; 17(4):265-9. PubMed ID: 15250915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential hypertension and the sympathetic nervous system.
    Grassi G; Quarti-Trevano F; Dell'oro R; Mancia G
    Neurol Sci; 2008 May; 29 Suppl 1():S33-6. PubMed ID: 18545892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.